The effect of intrauterine injection of plasma concentrated platelet on pregnancy rate

Evaluation of intrauterine Platelet Rich Plasma injection on pregnancy rate in women with implantation failure In Vitro Fertilization fertilization cycle

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180425039418N9

Enrollment

Registered

2019-11-09

Start date

2019-03-21

Completion date

Unknown

Last updated

2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

implantation failure. Female infertility, unspecified

Interventions

Intervention 1: Intervention group: All patients will receive 6 mg/d Estradiol valerate from the second day of the menstrual cycle until the endometrial thickness reaches 8 mm. When the endometrial th

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Not the Underlying Disease being at the Age of 20 to 40 2 or 3 times implantation failure history

Exclusion criteria

Exclusion criteria: Specific drug use Low quality embryos Endometrial growth not more than 8 mm

Design outcomes

Primary

Measure	Time frame
The number of pregnancies. Timepoint: Chemical and clinical pregnancy are respectively defined as positive serum level of B-hCG two weeks after embryo transfer, and fetal heart beat in trans-vaginal sonography five weeks after embryo transfer. Method of measurement: The structured checklist.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSara Ershadi

Zahedan University of Medical Sciences

sara_e1990@yahoo.com+98 54 3329 5620

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026